Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Systemic Immuno-metabolic alterations in chronic obstructive pulmonary disease (COPD).

Agarwal AR, Kadam S, Brahme A, Agrawal M, Apte K, Narke G, Kekan K, Madas S, Salvi S.

Respir Res. 2019 Jul 30;20(1):171. doi: 10.1186/s12931-019-1139-2.

2.

Superior Photo-thermionic electron Emission from Illuminated Phosphorene Surface.

Madas S, Mishra SK, Kahaly S, Kahaly MU.

Sci Rep. 2019 Jul 16;9(1):10307. doi: 10.1038/s41598-019-44823-x.

3.

Personal exposures to particulate matter <2.5 μm in mass median aerodynamic diameter (PM2.5) pollution during the burning of six most commonly used firecrackers in India.

Shah R, Limaye S, Ujagare D, Madas S, Salvi S.

Lung India. 2019 Jul-Aug;36(4):324-329. doi: 10.4103/lungindia.lungindia_440_18.

4.

Prevalence, risk factors and clinical correlates of COPD in a rural setting in Tanzania.

Magitta NF, Walker RW, Apte KK, Shimwela MD, Mwaiselage JD, Sanga AA, Namdeo AK, Madas SJ, Salvi SS.

Eur Respir J. 2018 Jan 31;51(2). pii: 1700182. doi: 10.1183/13993003.00182-2017. Print 2018 Feb.

5.

Challenges in recruitment and retention of clinical trial subjects.

Kadam RA, Borde SU, Madas SA, Salvi SS, Limaye SS.

Perspect Clin Res. 2016 Jul-Sep;7(3):137-43. doi: 10.4103/2229-3485.184820.

6.

Use of spirometry among chest physicians and primary care physicians in India.

Vanjare N, Chhowala S, Madas S, Kodgule R, Gogtay J, Salvi S.

NPJ Prim Care Respir Med. 2016 Jul 7;26:16036. doi: 10.1038/npjpcrm.2016.36.

7.

Opinions and perceptions regarding the impact of new regulatory guidelines: A survey in Indian Clinical Trial Investigators.

Kadam R, Borde S, Madas S, Nagarkar A, Salvi S, Limaye S.

Perspect Clin Res. 2016 Apr-Jun;7(2):81-7. doi: 10.4103/2229-3485.179437.

8.

Symptoms and medical conditions in 204 912 patients visiting primary health-care practitioners in India: a 1-day point prevalence study (the POSEIDON study).

Salvi S, Apte K, Madas S, Barne M, Chhowala S, Sethi T, Aggarwal K, Agrawal A, Gogtay J.

Lancet Glob Health. 2015 Dec;3(12):e776-84. doi: 10.1016/S2214-109X(15)00152-7.

9.

Indoor Particulate Matter < 2.5 μm in Mean Aerodynamic Diameter and Carbon Monoxide Levels During the Burning of Mosquito Coils and Their Association With Respiratory Health.

Salvi D, Limaye S, Muralidharan V, Londhe J, Madas S, Juvekar S, Biswal S, Salvi S.

Chest. 2016 Feb;149(2):459-466. doi: 10.1378/chest.14-2554. Epub 2016 Jan 12.

PMID:
26158857
10.

Reference values for peak expiratory flow in Indian adult population using a European Union scale peak flow meter.

Kodgule RR, Singh V, Dhar R, Saicharan BG, Madas SJ, Gogtay JA, Salvi SS, Koul PA.

J Postgrad Med. 2014 Apr-Jun;60(2):123-9. doi: 10.4103/0022-3859.132311.

11.

Priming of beta-2 agonist and antimuscarinic induced physiological responses induced by 1200mg/day NAC in moderate to severe COPD patients: A pilot study.

Sinojia R, Shaikh M, Kodgule R, Bhosale S, Madas S, Vaidya A, Salvi S, Brashier B.

Respir Physiol Neurobiol. 2014 Jan 15;191:52-9. doi: 10.1016/j.resp.2013.10.010. Epub 2013 Nov 7.

PMID:
24211316
12.

Bronchodilator efficacy of tiotropium-formoterol via single pressurized meter dose inhaler (pMDI) versus tiotropium alone in COPD.

Salvi S, Brashier B, Gothi D, Karkhanis V, Madas S, Gogtay J, Joshi J.

Pulm Pharmacol Ther. 2014 Feb;27(1):90-5. doi: 10.1016/j.pupt.2013.05.010. Epub 2013 Jun 8.

PMID:
23752057

Supplemental Content

Support Center